Effect of nomifensine on cortisol, prolactin and biogenic amines in neurotic depressed patients.
The effect of nomifensine on plasma levels of cortisol, prolactin, dopamine, noradrenaline, adrenaline and serotonin were studied in neurotic depressive patients. Cortisol levels were elevated in the morning and were significantly decreased by nomifensine treatment. Prolactin levels were within the normal range and nomifensine did not modify them. A significative increase in catecholamine plasma levels was observed at the 6th week of treatment in depressed patients (dopamine: 106%; noradrenaline: 14%; adrenaline: 10%) whose nomifensine plasma levels ranged between 84 and 105 ng/ml. No statistical differences were found between pre- and post-treatment serotonin concentration. Reduction of plasma cortisol and clinical improvement may be related to increased catecholamine levels.
D000328:Adult; D001679:Biogenic Amines / Q000097:blood*; D003866:Depressive Disorder / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood*; D007546:Isoquinolines / Q000627:therapeutic use*; D008875:Middle Aged; D009627:Nomifensine / Q000627:therapeutic use*; D011388:Prolactin / Q000097:blood*
D001679:Biogenic Amines; D007546:Isoquinolines; D009627:Nomifensine; D011388:Prolactin; D006854:Hydrocortisone